Gastrointestinal Cancer
From the Journals
Cell-Free DNA Blood Test Developed for Detecting Colorectal Cancer
The cfDNA blood test had 83% sensitivity for CRC, 90% specificity for advanced neoplasia, and 13% sensitivity for advanced precancerous lesions....
News from the FDA/CDC
FDA Approves New Esophageal Cancer Drug
The approval, which was deferred in 2022 due to COVID-19-related restrictions, marks the first for the agent in the United States.
From the Journals
Consider These Factors in an Academic Radiation Oncology Position
Editorial gives guidance to radiation oncologists seeking academic positions.
Feature
Look Beyond BMI: Metabolic Factors’ Link to Cancer Explained
A snapshot assessment of metabolic syndrome is inadequate to show an association with cancer risk over time, the authors of new research say.
Commentary
Survival Advantage of Adjuvant IO ‘Big News’ in Renal Cancer
The biggest news in kidney cancer at ASCO GU this year was the adjuvant...
Feature
ASTRO Pushes Return to Direct Supervision in RT: Needed or ‘Babysitting’?
But some radiation oncologists do not agree with the proposal to move back to direct in-person supervision only.
Feature
Does worsening metabolic syndrome increase the risk of developing cancer?
Elevated trajectories of metabolic syndrome were associated with an elevated overall cancer risk.
Feature
Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
What are the cancer types where exercise makes a difference?
From the Journals
Is Primary Tumor Resection Beneficial in Stage IV CRC?
How did overall survival in patients receiving primary tumor resection compare with that of patients receiving upfront chemotherapy?
News from the FDA/CDC
FDA Removes Harmful Chemicals From Food Packaging
The “major source of dietary exposure to PFAS from food packaging” is being eliminated.
Latest News
Low-Dose Aspirin Associated With Reduced CRC Risk
Observational study suggests prescription use of low-dose aspirin is linked to reduced risk of CRC, with greatest reduction in metastatic CRC.